Correlation Between NYSE Composite and Theravance Biopharma
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Theravance Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Theravance Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Theravance Biopharma, you can compare the effects of market volatilities on NYSE Composite and Theravance Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Theravance Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Theravance Biopharma.
Diversification Opportunities for NYSE Composite and Theravance Biopharma
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between NYSE and Theravance is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Theravance Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Theravance Biopharma and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Theravance Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Theravance Biopharma has no effect on the direction of NYSE Composite i.e., NYSE Composite and Theravance Biopharma go up and down completely randomly.
Pair Corralation between NYSE Composite and Theravance Biopharma
Assuming the 90 days trading horizon NYSE Composite is expected to generate 2.48 times less return on investment than Theravance Biopharma. But when comparing it to its historical volatility, NYSE Composite is 4.24 times less risky than Theravance Biopharma. It trades about 0.24 of its potential returns per unit of risk. Theravance Biopharma is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 877.00 in Theravance Biopharma on August 27, 2024 and sell it today you would earn a total of 70.00 from holding Theravance Biopharma or generate 7.98% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Theravance Biopharma
Performance |
| Timeline |
NYSE Composite and Theravance Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Theravance Biopharma
Pair trading matchups for Theravance Biopharma
Pair Trading with NYSE Composite and Theravance Biopharma
The main advantage of trading using opposite NYSE Composite and Theravance Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Theravance Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theravance Biopharma will offset losses from the drop in Theravance Biopharma's long position.| NYSE Composite vs. Hooker Furniture | NYSE Composite vs. Hudson Pacific Properties | NYSE Composite vs. Canlan Ice Sports | NYSE Composite vs. Boston Properties |
| Theravance Biopharma vs. Instil Bio | Theravance Biopharma vs. Achilles Therapeutics PLC | Theravance Biopharma vs. NextCure | Theravance Biopharma vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |